Letter by Krötz et al regarding article, "Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure"

MeSH terms

• Endothelium, Vascular / drug effects
• Endothelium, Vascular / enzymology
• Enzyme Inhibitors / adverse effects
• Enzyme Inhibitors / pharmacology*
• Humans
• Intracellular Signaling Peptides and Proteins / antagonists & inhibitors*
• Nitric Oxide / metabolism
• Phosphorylation / drug effects
• Protein Processing, Post-Translational / drug effects*
• Protein Tyrosine Phosphatase, Non-Receptor Type 1
• Protein Tyrosine Phosphatase, Non-Receptor Type 11
• Protein Tyrosine Phosphatase, Non-Receptor Type 6 / antagonists & inhibitors*
• Protein Tyrosine Phosphatases / antagonists & inhibitors*
• Substrate Specificity